FOXD4 is a forkhead box transcription factor that functions as a sequence-specific DNA-binding transcription factor regulating RNA polymerase II-dependent gene expression 1. The human genome contains seven FOXD4-related genes (FOXD4 and FOXD4L1-L6) generated through recent gene duplication, unlike the single mouse ortholog 2. FOXD4 contains functionally distinct domains: an N-terminal acidic blob region mediating transcriptional activation and a C-terminal Eh-1 motif enabling Groucho co-repressor interaction for transcriptional repression 3. During embryonic neural development, FOXD4 maintains proliferative neural ectodermal precursors while suppressing genes promoting neural differentiation, regulating the critical transition from immature to differentiating neural tissue 4. Pathologically, FOXD4 mutations have been associated with dilated cardiomyopathy, obsessive-compulsive disorder, and suicidality, with a W148R mutation disrupting conserved DNA-binding capacity 5. In colorectal adenocarcinoma, elevated FOXD4 expression correlates with poor prognosis and serves as a diagnostic biomarker (AUC=0.728) 6. Additionally, structural variants impacting FOXD4 have been identified as candidate contributors to neural tube defects 7. These findings establish FOXD4 as a developmentally critical transcriptional regulator with pathogenic potential in congenital and malignant diseases.